Jiang Tongtian
About Jiang Tongtian
Jiang Tongtian is a Quality Assurance Auditor at BeiGene with over a decade of experience in the pharmaceutical industry, holding a Master's degree in Clinical Medicine from Fudan University.
Title
Jiang Tongtian currently holds the position of Quality Assurance Auditor at BeiGene. With a role deeply involved in maintaining compliance and enhancing the quality of pharmaceutical operations, Jiang's expertise is crucial to the company's success.
Education and Expertise
Jiang Tongtian studied Clinical Medicine at Fudan University, obtaining a Master's degree over a seven-year period from 2003 to 2010. This academic foundation has been pivotal in Jiang's career, providing a robust understanding of clinical research and quality assurance principles which are essential in the pharmaceutical industry.
Professional Background
Jiang Tongtian began a career in the pharmaceutical industry over a decade ago. Jiang's extensive experience spans several leading pharmaceutical companies, including Pfizer, MSD, and Sanofi, before joining BeiGene in July 2019. The roles ranged from Clinical Research Associate to Quality Specialist, showcasing a diverse skill set and dedication to pharmaceutical quality control.
Previous Roles
Jiang's career includes significant roles in major pharmaceutical firms. From 2013 to 2014, Jiang worked at Pfizer as a Clinical Research Associate. This was followed by a three-year stint at MSD, also as a Clinical Research Associate, from 2014 to 2017. The next role was at Sanofi as a Quality Specialist, from 2017 to 2019, in Shanghai City, China. These positions have enriched Jiang’s proficiency in both clinical research and quality assurance.
Current Position at BeiGene
As of July 2019, Jiang is serving as a Quality Assurance Auditor for BeiGene in Shanghai City, China. In this role, Jiang is responsible for ensuring that the company’s pharmaceutical products meet stringent quality standards and regulatory requirements, contributing to the development of safe and effective medicines.